Jinan Li

This inventor holds 19 USPTO granted patents and 15 published patent applications and 18 EPO patents, primarily in Medical Treatment. Top assignee: Talengen International Limited. Active years: 2020-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jinan Li. Retrieved from https://idiyas.com/inventor/jinan-li

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 19 (Patent Applications = 15)

% Patents Active = 100.0

EPO Patents = 18 (Patent Applications = 40)

Average Co-Inventor Count = 1.0

ph-index = 2

Forward Citations = 17(Granted Patents)

Location History:

Shenzhen, CN (2020 - 2023)
Guangdong, CN (2020 - 2024)

Company Filing History:

19 out of 20

Talengen International Limited

patents

Years Active: 2020-2026

Loading Chart...

Areas of Expertise:

Spinal Muscular Atrophy

GLP-1

Osteoarthritis

Coronary Atherosclerosis

Fatty Liver

Heart Disease

Angiocardiopathy

Insulin

Liver Fibrosis

Obesity

Pulmonary Fibrosis

Diabetic Retinopathy

19 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12576139 - METHOD AND DRUG FOR TREATING SPINAL MUSCULAR ATROPHY (2026-03-17),

2. 11938172 - Method for regulating and controlling GLP-1/GLP-1R and drug (2024-03-26),

3. 11642397 - Method and drug for preventing or treating osteoarthritis (2023-05-09),

4. 11547746 - Method for treating coronary atherosclerosis and complications thereof (2023-01-10),

5. 11478535 - Method for preventing and treating fatty liver (2022-10-25),

6. 11400142 - Treatment of diabetic nerve injury comprising administering plasminogen (2022-08-02),

7. 11389515 - Method for mitigating heart disease (2022-07-19),

8. 11338022 - Method for preventing and treating angiocardiopathy (2022-05-24),

9. 11311607 - Method for making glucagon and insulin restore normal balance (2022-04-26),

10. 11219669 - Method for preventing and treating liver fibrosis (2022-01-11),

11. 11207387 - Method and drug for preventing and treating obesity (2021-12-28),

12. 11154595 - Method for preventing and treating pulmonary fibrosis (2021-10-26),

13. 11129880 - Method for promoting insulin secretion (2021-09-28),

14. 11090372 - Method of treating diabetic nephropathy comprising administering plasminogen (2021-08-17),

15. 11071772 - Method for preventing and treating tissue and organ fibrosis (2021-07-27),

Title: Jinan Li: Pioneering Innovations in Medical Treatments

Introduction

Jinan Li, a distinguished inventor based in Guangdong, China, has made significant contributions to the field of medical treatments through his innovative approaches. With 18 patents to his name, he is recognized for his dedication to enhancing healthcare solutions.

Latest Patents

Among Jinan Li's notable inventions are his latest patents, which focus on the regulation and control of GLP-1/GLP-1R and addressing osteoarthritis. The first patent discloses a method utilizing plasminogen to regulate GLP-1/GLP-1R, aimed at treating conditions related to GLP-1/GLP-1R. The second patent outlines a method and a drug designed to prevent or treat osteoarthritis, detailing the administration of plasminogen to patients for effective treatment. Furthermore, this invention includes an osteoarthritis treatment drug comprising plasminogen, along with a product and a kit for enhanced patient care.

Career Highlights

Jinan Li is currently affiliated with Talengen International Limited, where he applies his expertise in developing groundbreaking medical therapies. His work reflects a commitment to advancing the understanding of complex biological processes and improving treatment options for various conditions.

Collaborations

Throughout his career, Jinan Li has engaged in collaborations with fellow researchers and institutions, fostering an environment of innovation and knowledge sharing. His partnerships are aimed at accelerating the development of effective therapeutic solutions and enhancing the overall impact of his inventions.

Conclusion

Jinan Li stands as a prominent figure in the realm of medical innovation, employing his ingenuity to address pressing health issues. His patents, particularly regarding GLP-1/GLP-1R regulation and osteoarthritis treatment, demonstrate his commitment to improving patient outcomes and advancing healthcare methodologies. As he continues his work at Talengen International Limited, the future holds promising advancements driven by his innovations.

Profile summary based on public USPTO records.